Guidelines for the management of epilepsy in the elderly

Acta Neurologica Belgica

Volumn 106, Issue 3, 2006, Pages 111-116

  Ossemann, M ^a   Bruls, E ^b   de Borchgrave, V ^b   De Cock, C ^b   Delcourt, C ^b   Delvaux, V ^b   Depondt, C ^b   de Tourchaninoff, M ^b   Grisar, T ^b   Legros, B ^b   Lienard F ^b   Lievens, I ^b   Sadzot, B ^b   van Rijckevorsel, K ^b  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b NONE

Author keywords

Elderly; Epilepsy; Management

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM; CARBAMAZEPINE; DIURETIC AGENT; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; VITAMIN D;

ARTICLE; BELGIUM; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSENSUS DEVELOPMENT; DEGENERATIVE DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; DRUG CLEARANCE; DRUG COMPETITION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC DISCHARGE; FOCAL EPILEPSY; HUMAN; HYPONATREMIA; INCIDENCE; OSTEOPOROSIS; PRACTICE GUIDELINE; RECURRENCE RISK;

EID: 33750296509     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hauser W. A., Annegers J. F., Kurland L. T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia, 1993, 34: 453-468.
2. Sander J. W., Hart Y. M., Johnson A. L., Shorvon S. D. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet, 1990, 336: 1267-1271.
3. Ramsay R. E., Rowan A. J., Pryor F. M. Special considerations in treating the elderly patient with epilepsy. Neurology, 2004, 62: 24S-29.
4. Drury I., Beydoun A. Pitfalls of EEG interpretation in epilepsy. Neurol. Clin., 1993, 11: 857-881.
5. Santamaria J., Chiappa K. H. The EEG of drowsiness in normal adults. J. Clin. Neurophysiol., 1987, 4: 327-382.
6. Dam A. M., Fuglsang-Frederiksen A., Svarre-Olsen U., Dam M. Late-onset epilepsy: etiologies, types of seizure, and value of clinical investigation, EEG, and computerized tomography scan. Epilepsia, 1985, 26: 227-231.
7. Henny C., Despland P. A., Regli F. Première crise épileptique après l'âge de 60 ans : étiologie, présentation clinique et EEG. Schweiz. Med. Wochenschr., 1990, 120: 787-792.
8. Drury I., Beydoun A. Interictal epileptiform activity in elderly patients with epilepsy. Electroencephalogr. Clin. Neurophysiol., 1998, 106: 369-373.
9. Loiseau J., Crespel A., Picot M. C., Duche B., Ayrivie N. et al. Idiopathic generalized epilepsy of late onset. Seizure, 1998, 7 : 485-487.
10. Hiyoshi T., Yagi K. Epilepsy in the elderly. Epilepsia, 2000, 41 Suppl 9: 31-35.
11. Gastaut H. [Individualization of so-called benign and functional epilepsy at different ages. Appraisal of variations corresponding the predisposition for epilepsy at these ages]. Rev. Electroencephalogr. Neurophysiol. Clin, 1981, 11: 346-366.
12. Gastaut H. "Benign" or "functional" (versus "organic") epilepsies in different stages of life: an analysis of the correpsonding age-related variations in the predisposition to epilepsy. In: Henri Gastaut and the Marseilles school's contribution to the neurosciences (EEG Suppl. No 35). Broughton R. J. (ed.). Amsterdam: Elsevier Biomedical Press, 1982, 17-44.
13. Sung C. Y., Chu N. S. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurol. Scand., 1989, 80: 51-56.
14. Loiseau J., Loiseau P., Duche B., Guyot M., Dartigues J. F. et al. A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann. Neurol., 1990, 27: 232-237.
15. Berges S., Moulin T., Berger E., Tatu L., Sablot D. et al. Seizures and epilepsy following strokes: recurrence factors. Eur. Neurol., 2000, 43: 3-8.
16. Louis S., McDowell F. Epileptic seizures in nonembolic cerebral infarction. Arch. Neurol., 1967, 17: 414-418.
17. Kilpatrick C. J., Davis S. M., Hopper J. L., Rossiter S. C. Early seizures after acute stroke. Risk of late seizures. Arch. Neurol., 1992, 49: 509-511.
18. Arboix A., Garcia-Eroles L., Massons J. B., Oliveres M., Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke, 1997, 28: 1590-1594.
19. Reith J., Jorgensen H. S., Nakayama H., Raaschou H. O., Olsen T. S. Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke, 1997, 28: 1585-1589.
20. Burn J., Dennis M., Bamford J., Sandercock P., Wade D. et al. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ, 1997, 315: 1582-1587.
21. So E. L., Annegers J. F., Hauser W. A., O'Brien P. C., Whisnant J. P. Population-based study of seizure disorders after cerebral infarction. Neurology, 1996, 46: 350-355.
22. So E. L., Annegers J. F., Hauser W. A., O'brien P. C., Whisnant J. P. Population-based study of seizure disorders after cerebral infarction. Neurology, 1996, 46: 350-355.
23. Gupta S. R., Naheedy M. H., Elias D., Rubino F. A. Postinfarction seizures. A clinical study. Stroke, 1988, 19: 1477-1481.
24. Kilpatrick C. J., Davis S. M., Hopper J. L., Rossiter S. C. Early seizures after acute stroke. Risk of late seizures. Arch. Neurol., 1992, 49: 509-511.
25. Milandre L., Broca P., Sambuc R., Khalil R. Les crises épilepstiques au cours at au décours des accidents cérébrovasculaires. Analyse clinique de 78 cas. Rev. Neurol. (Paris), 1992, 148: 767-772.
26. Ossemann M. Crises épileptiques et épilepsies d'origine vasculaire: caractéristiques cliniques, électroencéphalographiques et scannographiques. Rev. Neurol. (Paris), 2002, 158: 256-259.
27. Cleary P., Shorvon S., Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet, 2004, 363: 1184-1186.
28. Hauser W. A., Morris M. L., Heston L. L., Anderson V. E. Seizures and myoclonus in patients with Alzheimer's disease. Neurology, 1986, 36 : 1226-1230.
29. Hesdorffer D. C., Hauser W. A., Annegers J. F., Kokmen E., Rocca W. A. Dementia and adult-onset unprovoked seizures. Neurology, 1996, 46 : 727-730.
30. Hauser W. A., Rich S. S., Annegers J. F., Anderson V. E. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology, 1990, 40: 1163-1170.
31. Rocca W. A., Sharbrough F. W., Hauser W. A., Annegers J. F., Schoenberg B. S. Risk factors for complex partial seizures: a population-based case-control study. Ann. Neurol., 1987, 21: 22-31.
32. Hauser W. A., Rich S. S., Annegers J. F., Anderson V. E. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology, 1990, 40: 1163-1170.
33. Van Donselaar C. A., Geerts A. T., Schimsheimer R. J. Idiopathic first seizure in adult life: who should be treated? BMJ, 1991, 302: 620-623.
34. First Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group). Neurology, 1993, 43: 478-483.
35. De Borchgrave V., Delvaux V., De Tourchaninoff M., Dubru J. M., Ghariani S. et al. Therapeutic strategies in the choice of antiepileptic drugs. Acta Neurol. Belg., 2002, 102: 6-10.
36. Christiansen C., Rodbro P., Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br. Med. J., 1973, 4: 695-701.
37. Legros B., Bottin P., De B., V. Delcourt C., De Tourtchaninoff M. et al. Therapeutic issues in women with epilepsy. Acta Neurol Belg., 2003, 103: 135-139.
38. Tudur S. C., Marson A. G., Williamson P. R. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane. Database. Syst. Rev., 2001,CD001769.
39. French J. A., Kanner A. M., Bautista J., About-Khalil B., Browne T. et al. Efficacy and tolerability of the new antiepileptic drugs I : treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2004, 62: 1252-1260.
40. Brodie M. J., Overstall P. W., Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res., 1999, 37: 81-87.
41. Rowan A.J., Ramsay R.E., Collins J. F., Pryor F., Boardman K. D. et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology, 2005, 64: 1868-1873.
42. Groselj J., Guerrini R., Van Oene J., Lahaye M., Schreiner A. et al. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurologica Scandinavica, 2005, 112 : 144-150.
43. Chadwick D. W., Anhut H., Greiner M. J., Alexander J., Murray G. H. et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology, 1998, 51: 1282-1288.
44. Cramer J. A., Leppik I. E., Rue K. D., Edrich P., Kramer G. Tolerability of levetiracetam in elderly patients with CNS disorders. Epilepsy Research, 2003, 56: 135-145.
45. Ferrendelli J. A., French J., Leppik I., Morrell M. J., Herbeuval A. et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy & Behavior, 2003, 4: 702-709.
46. Alsaadi T. M., Koopmans S. U. Z. A., Apperson M. I. C. H., Farias S. A. R. A. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure, 2004, 13: 58-60.
47. Kutluay E., McCague K., D'souza J., Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav., 2003, 4: 175-180.
48. Schmidt D., Arroyo S., Baulac M., Dam M., Dulac O. et al. Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view. Acta Neurol. Scand., 2001, 104: 167-170.